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Introduction
Type 1 diabetes (T1D) is an organ-specific autoimmune disease characterized by the destruction of insulin-secreting β cells in the pancreas (1). Although the disease is mainly driven by diabetogenic T cells, B lymphocytes also play an important role in disease development. B cell-deficient (μMT -/-) NOD mice rarely develop diabetes (2, 3) , and temporarily depleting B cells with specific antibody can prevent and reverse T1D in NOD mice (3) (4) (5) (6) (7) . Treatment with rituximab (anti-human CD20) can also reduce the loss of C-peptide in patients with T1D (8) . B cells contribute to islet autoimmunity, both as secretors of pathogenic autoantibodies and through the activation of autoreactive T cells (9) . Patients with T1D display defective central and peripheral B cell tolerance, as shown by the accumulation of self-reactive, mature naive B cells in the peripheral blood (10) .
Activation-induced cytidine deaminase (AID), an important enzyme for B cell function, is responsible for the initiation of the somatic hypermutation and class-switch recombination. This facilitates development of Ig diversity and specificity for the recognition of intruding pathogens through humoral immunity governed by B cells (11) (12) (13) (14) . Furthermore, AID is critical for the maintenance of B cell tolerance through its removal of pathogenic B cells through apoptosis in both bone marrow and germinal centers (GCs), and its ablation results in the accumulation of large numbers of autoreactive B cells in the sera of AID-deficient (AID -/-) patients (15, 16) . B cells with AID mutations fail to have normal Ig class-switching and can only secrete IgM, and this leads to hyper-IgM syndrome in mice and humans (17) . Approximately 25% of patients with hyper-IgM syndrome have presented with different autoimmune manifestations (10, 18, 19) . In mice, AID deficiency is also correlated with autoimmune diseases (11, 20, 21) . Conversely, a study by Jiang et al. showed that AID deficiency correlated with a reduction in autoreactive B cells, a decrease in T cell activation, and a B cells play an important role in type 1 diabetes (T1D) development. However, the role of B cell activation-induced cytidine deaminase (AID) in diabetes development is not clear. We hypothesized that AID is important in the immunopathogenesis of T1D. To test this hypothesis, we generated AID-deficient (AID -/-) NOD mice. We found that AID -/-NOD mice developed accelerated T1D, with worse insulitis and high levels of anti-insulin autoantibody in the circulation. Interestingly, neither maternal IgG transferred through placenta, nor IgA transferred through milk affected the accelerated diabetes development. AID + T cells caused more rapid onset of diabetes when cotransferred with AID -/-B cells than when cotransferred with AID +/+ B cells. Thus, our study provides insights into the role of AID in T1D. Our data also suggest that AID is a negative regulator of immune tolerance and ablation of AID can lead to exacerbated islet autoimmunity and accelerated T1D development.
decrease in kidney lymphocytic infiltration in a lupus mouse model (JHT.mIg.MRL/lpr), where the mice had mIg only but were unable to secrete any Igs (22) . The authors suggested that AID acts as an important contributor to the antibody-independent role of B cells in autoimmunity. These observations demonstrate that AID plays an important role, either to promote or prevent the development of autoimmune diseases. However, the role of AID in T1D remains unclear.
Given the importance of B cells in T1D development, we hypothesized that AID contributes to the immunopathogenesis of the disease. To test our hypothesis, we generated AID -/-NOD mice. Unlike the results in a very recent report (23), we found that AID -/-NOD mice developed accelerated T1D with increased anti-insulin antibody in the circulation and enhanced insulitis in the pancreatic islets. Further mechanistic studies demonstrated significantly increased expansion and activation of autoimmune B cells in the absence of AID. The activated B cells effectively facilitated activation of T cells in vitro, enhanced diabetogenic T-B cell interaction, and accelerated diabetes development in vivo.
Results
AID deficiency accelerates T1D development in NOD mice. To study whether AID plays a role in the development of T1D, we backcrossed AID -/-C57BL/6 mice onto the NOD genetic background for more than 10 generations. The purity of the NOD genetic background, including the known Idd loci, was verified by Illumina SNP chip (DartMouse, data not shown). Diabetes development was significantly accelerated in female AID -/-NOD mice, with a higher disease incidence, compared with female AID-sufficient littermates that were AID +/+ NOD or AID +/-NOD, which developed similar diabetes incidence to each other ( Figure  1A ). No statistical differences in the diabetes development were seen in male AID NOD group (60.6% vs. 53.0%), as evaluated by insulitis score ( Figure 1B) . We analyzed the infiltrated lymphocytes from the islets by flow cytometry and found that both CD4 + and CD8 + T cells were significantly more abundant in the islets from AID -/-NOD mice, compared with control mice (AID-sufficient mice, including both AID +/+ NOD and AID +/-NOD mice, as no difference was found between them, in either diabetes development or other phenotypic characteristics) ( Figure 1C ). Further staining with islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP, an autoantigen in both NOD and human T1D) tetramer demonstrated a significant increase in both the frequency and absolute number of IGRP-autoreactive CD8 + T cells in the islet infiltrates of AID -/-NOD mice compared with control mice ( Figure 1D and Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/jci. insight.95882DS1). AID deficiency does not affect pancreatic islet development, as AID -/-NOD mice had similar numbers of islets compared with control mice (Supplemental Figure 1B) . Our data demonstrated that AID plays an important role in immune tolerance to islet β cells and AID deficiency promotes autoreactive cell infiltration into islets and exacerbates T1D development.
Maternal class-switched Igs are dispensable to T1D development. B cells deficient in AID fail to undergo class-switch recombination and produce class-switched Ig isotypes, especially IgG and IgA. These two major class-switched Ig isotypes were undetectable in the circulation of AID NOD counterparts ( Figure 2D ). All the IAAs in AID -/-NOD mice were of the IgM isotype (Supplemental Figure 2) . It is known that maternal IgG can cross the placenta to the fetus and maternal milk is also rich in classswitched Igs, especially IgA, all of which contribute to the circulating Igs in neonates and provide protection from infections in early life (24) . Although adult AID NOD progeny had undetectable serum IgA, even at a very young age, and IgA continued to be absent ( Figure 2G ). In AID +/-littermates, serum IgA increased between 30 and 40 days of age, and the levels remained steady afterward ( Figure  2G ). In contrast, there was a significant decline of serum IgG in AID -/-NOD mice during this period ( Figure  2E ). These data suggest that AID -/-NOD pups received maternal IgG through the placenta and possibly also from breast feeding but gradually lost these antibodies with age, especially after weaning (before 30 days). At the same time as the reduction of circulating IgG, AID -/-NOD mice showed a marked increase in serum IgM, and the levels of serum IgM continued to be high ( Figure 2F ). To test whether early exposure to maternal IgG affected diabetes development, we set up additional breeding pairs by breeding female AID NOD and control mice were stained with IGRP-tetramer, CD45, CD8, and TCRβ followed with FACS analysis. n = 4 mice/group. *P < 0.05; **P < 0.01; ***P < 0.001, Gehan-Breslow-Wilcoxon survival test (A), χ 2 test (B), and Student's t test (C and D).
3B and data not shown). To investigate whether the lymphocytic expansion was correlated with enhanced cell proliferation, we performed in vivo BrdU incorporation assays. There was significantly increased pro- Individual data and mean ± SEM of 1 of the 2 independent experiments are shown. n = 4 mice/ group. *P < 0.05; **P < 0.01; ***P < 0.001, multiple t test. PLN, pancreatic lymph nodes; MLN, mesenteric lymph nodes; PP, Peyer's patches; SSC, side scatter. NOD mice were stained for the transcription factor T-bet and intracellular IFN-γ and analyzed by flow cytometry. Representative flow cytometric plots of splenic IFN-γ-and T-bet-expressing cells are shown as well as the summary of T-bet and IFN-γ expression, shown as mean ± SEM. This experiment was repeated 3 times. n = 6 mice/group. *P < 0.05; **P < 0.01; ***P < 0.001, multiple t test. PLN, pancreatic lymph nodes; MLN, mesenteric lymph nodes; PP, Peyer's patches; SSC, side scatter. Figure 5H ). Our data suggest that, in the absence of AID, B cells are more activated and more effective at promoting diabetogenic CD4 + T cell activation and proliferation and enhancing the action of autoantigen-specific T cells.
Discussion
In our study, we have shown that the AID deficiency accelerated and increased autoimmune diabetes in the NOD mouse. In the absence of AID, NOD mice also developed a lymphoproliferative phenotype in different lymphoid tissues. Moreover, both T and B cells were more activated and inflammatory. The B cells lacking functional AID were also more autoreactive, as shown by the excessive production of IAA in the circulation and by the enhanced facilitation of diabetogenic T cells that cause T1D when cotransferred to immunodeficient hosts. Thus, our results suggest that under normal circumstances, in addition to the role in antibody class-switching, AID is important in maintenance of immune tolerance to islet β cell autoimmunity. A number of lines of evidence suggest that B cells may play multiple roles in the development of diabetes. B cell-deficient NOD mice do not develop diabetes (3, 6) , and impaired signaling of the B cell receptor protects NOD mice from diabetes development as well (27) . The antigen-presenting function of B cells is also important for T1D development (2, 28) . We have previously shown that B cell-deficient μMT NOD mice, which have transgenic expression of membrane-bound IgM (mIg) but are unable to secrete any switched isotypes of Igs, restored the B cell compartment to a normal level, as found in NOD mice (3). The expression of mIg also restored diabetes development in 16% of the mice, compared with B cell-deficient μMT NOD mice, which had only 1.5% incidence of diabetes (3). However, the incidence of diabetes in mIg μMT NOD mice was much lower than that seen in WT normal NOD mice, indicating that antibody production by B cells and a broad B cell repertoire may also be important for T1D development.
Autoantibody production is a characteristic of many autoimmune diseases, including lupus, rheumatoid arthritis, and autoimmune hepatitis. Autoantibodies contribute to the pathology of the targeted tissues via activation of complement system, formation and deposition of immune complexes, stimulation of phagocytes, and induction of inflammation (29, 30) . Although the role of the autoantibodies in T1D is not completely understood, autoantibodies against GAD, IA2, and insulin are important biomarkers for diagnosis and prediction of T1D development (31-33). AID is an essential enzyme for the production of all classswitched antibodies, and, in the absence of AID, B cells in both mice and humans can only produce IgM. As expected in the AID -/-NOD mice, IgM was increased, whereas IgA and IgG were virtually undetectable. By preventing the generation of IgG, lack of AID negates the normal negative feedback mediated by IgG interaction with the inhibitory IgG Fc receptor expressed principally on B cells, FcγRIIB (34, 35) . This removes a natural brake on immune tolerance, and this may be an important contributor to the increase in autoantibodies. While autoantibodies are usually of the IgG isotype, we found that, in the absence of AID, there was enhanced production of IgM insulin autoantibodies. The ability to transmit autoantibodies from mother to the offspring has previously been shown to be important in inducing diabetes (36) . It is known that IgM cannot transmit through the placenta, and yet the incidence of diabetes in offspring of mothers that could not transmit antibodies was not different to the diabetes incidence in the offspring of the mothers that were able to transmit class-switched antibodies. To test whether the IgM has a causal role in accelerating diabetes, we infused sera from AID NOD or NOD.scid mice (4-5 weeks old), followed by observation for diabetes development. Data were pooled from at least 2 independent experiments (A, C, D, and G) or 1 of over 3 individual experiments (B, E, and F). *P < 0.05; **P < 0.01; ***P < 0.001, multiple testing with Bonferroni correction (A, D, and F), 2-tailed Student's t test (B and C), 2-way ANOVA (E), and Gehan-Breslow-Wilcoxon survival test (G). Data are shown as mean ± SEM. ment induced by BDC2.5 CD4 + T cells (Supplemental Figure 5) . Thus, the accelerated diabetes development in AID -/-NOD mice is most likely a reflection of the loss of tolerance due to the AID deficiency. The effect of AID deficiency on other B cell subsets was not obvious, except that there was an increased number of follicular B cells (Supplemental Figure 6, A-C) . The increase of follicular B cells is in line with an even greater increase of GC B cells in the absence of AID. In GCs, B cells undergo affinity maturation that leads to the production of high-affinity, antigen-specific antibodies via mutations in the Ig locus controlled by AID (37) . AID deficiency results in impaired GC reactions, which leads to the expansion of self-reactive B cell clones (38, 39) . Furthermore, AID deficiency may also enhance the escape of these pathogenic B cell clones from GCs of peripheral lymphoid tissues by evading the selection pressures and circulating to target the systemic host organs (39) . AID (23) , in which the results obtained could be due to the different approach used for genetic targeting and a different environment. Foxp3 + Tregs were also not affected here by AID deficiency in our model system. It is possible that a third party, including dendritic cells, might be involved in the accelerated autoimmunity in the absence of AID. Further investigation is required to examine this possibility.
In summary, we have reported that AID ablation accelerated T1D development in NOD mice by loss of B cell tolerance, together with increased B cell activation, proliferation, and enhanced autoantibody production. This increased the ability to promote Th1 T cells in vitro and facilitated the diabetogenic T cells in islet β cell destruction in vivo. Importantly, maternally transmitted class-switched Igs do not affect diabetes development. Taken together, the finding from the current study adds knowledge to our understanding the role of AID in autoimmune diabetes and provides insight into the possible therapeutic targets for the prevention or treatment of T1D in the future.
Methods
Mice. NOD/Caj mice were originally obtained from The Jackson Laboratory and have been maintained at Yale University for over 30 years. AID -/-NOD mice were generated by backcrossing AID -/-B6 mice (a gift from Tasuku Honjo, Kyoto University, Kyoto, Japan) to the NOD/Caj genetic background for more than 10 generations. The purity of the NOD genetic background was examined by whole-genome single nucleotide polymorphism scan (DartMouse). BDC2.5 NOD, Rag2 -/-NOD, and NOD.scid mice were all originally obtained from The Jackson Laboratory. All the mice were kept in specific pathogen-free conditions in a 12-hour-dark/light cycle and housed in individually ventilated filter cages with autoclaved food in the Yale University animal facility.
Antibodies and reagents. All the fluorochrome-conjugated mAbs used in this study were purchased from Biolegend except anti-Foxp3 (150D), which was from eBioscience. They include anti-B220 (RA3-6B2), anti-BrdU (3D4), anti-CD4 (GK1.5), anti-CD8 ( NOD male mice, respectively. All breeders were >7 weeks old and nondiabetic. Diabetes development was also observed in the offspring. Mice were tested for glycosuria weekly, and diabetes was confirmed by blood glucose ≥250 mg/dl (13.9 mmol/l). For some mechanistic studies, we bred AID NOD mice, in some experiments, we used both genotypes as AID -/-controls. Histology of pancreatic tissues. Pancreatic tissues were fixed with 10% buffered formalin, embedded in paraffin, sectioned at a thickness of 5 μm, and then stained with hematoxylin and eosin and examined under light microscopy. Insulitis was scored under light microscopy with the following grading scale: 0, no infiltration; 1, <25% infiltration of the islet; 2, 25%-75% infiltration of the islet; and 3, >75% islet infiltration. More than 100 islets were scored for insulitis in each group (n = 8-9 mice/group).
Isolation of infiltrated immune cells from pancreatic islets. Pancreata were removed from the mice, placed in 1 mg/ml collagenase solution, and digested at 37°C in a water bath for 8-10 minutes. Islets were handpicked under a microscope after the enzymatic digestion. The islet-infiltrating cells were harvested from the handpicked islets after further dissociation with Cell Dissociation Solution Non-Enzymatic (MilliporeSigma), followed by filtering using nylon membranes. The infiltrated cells were then stained with different antibodies for flow cytometric analysis. NOD male breeding, on day 30 after birth and every 10 days thereafter. Serum Igs were quantitated by ELISA. Briefly, the plates were coated with goat anti-mouse IgH+L (10 μg/ml, SouthernBiotech) antibody overnight. After washing and blocking the plates, diluted serum samples were added to the plates and assessed against known concentrations of the standard. The plates were incubated at room temperature for 2 hours followed by adding AP-conjugated goat anti-mouse IgG, IgM, or IgA. The detection of different Ig isotypes was determined by enzymatic reaction of AP and phosphate substrate (MilliporeSigma). The plates were read with a microplate spectrophotometer (Perkin Elmer) under OD at 405 nm, and the concentrations of different isotypes were determined by standard curves for each isotype. + T cells (3 × 10 6 /mouse). All the recipients were screened for diabetes development by testing for glycosuria daily, and the experiments were terminated 20-32 days after the cell transfer unless the mice developed diabetes, which was confirmed by blood glucose ≥250 mg/dl (13.9 mmol/l).
Statistics. Statistical analysis was performed using GraphPad Prism software version 6.0. Diabetes incidence was compared using the Gehan-Breslow-Wilcoxon test. In vitro assays were analyzed with the 2-tailed Student's t test, multiple t tests with FDR or Bonferroni correction, or ANOVA. P < 0.05 was considered significant.
Study approval. The use of the animals and the procedures applied in this study were reviewed and approved by the Institutional Animal Care and Use Committee of Yale University.
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